Tumour necrosis factor-alpha (TNF-alpha) plays a central role in infla
mmatory events including those taking place in the central nervous sys
tem (CNS), and has been implicated as a key pathogenicc mediator in se
veral human inflammatory, infectious and autoimmune CNS disorders. Usi
ng transgenic and gene knockout mice we have investigated the role of
deregulated TNF-alpha production in the CNS. We show that the overexpr
ession of wild-type murine or human TNF-alpha transgenes by resident C
NS astrocytes or neurons in sufficient to trigger a neurological disor
der characterised by ataxia, seizures and paresis, with histopathologi
cal features of chronic CNS inflammation and white matter degeneration
. Furthermore, we show that transmembrane human TNF-alpha is sufficien
t to trigger CNS inflammation and degeneration when overexpressed by a
strocytes but not by neurons, indicating that target cells mediating t
he neuroinflammatory activities of TNF-alpha localise in the vicinity
of astrocytes rather than neurons. Our results establish that both sol
uble and transmembrane molecular forms of TNF-alpha can play critical
roles in vivo in the pathogenesis of CNS inflammation and demyelinatio
n, and validate TNF-alpha transgenic and mutant mice as important mode
ls for the further study of related human CNS diseases.